id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
aiua-10985	Masuda, Hiroshi; Mikami, Kosuke; Otsuka, Kotaro; Hou, Kyokusin; Suyama, Takahito; Araki, Kazuhiro; Kojima, Satoko; Naya, Yukio	Outcomes of dutasteride discontinuation in patients with benign prostatic hypertrophy	2022	4	.pdf	application/pdf	3114	158	57	In both groups, age, body mass index (BMI), International Prostate Symptom Score (IPSS), quality-of-life (QoL) score, Overactive Bladder Symptom Score (OABSS), duration of dutasteride treatment before Outcomes of dutasteride discontinuation in patients with benign prostatic hypertrophy Hiroshi Masuda, Kosuke Mikami, Kotaro Otsuka, Kyokusin Hou, Takahito Suyama, Kazuhiro Araki, Satoko Kojima, Yukio Naya Department of Urology, Teikyo University Chiba Medical Center, 3426-3 Anesaki, Ichihara, Chiba 299-0111, Japan. A longer dutasteride treatment before discontin- uation could be associated with a greater effect of prostate shrinkage that could be maintained for a longer period after dutasteride discontinuation so delaying restarting of dutasteride treatment, on the contrary we observed the opposite in this study.	cache/aiua-10985.pdf	txt/aiua-10985.txt